Skip to content

10-Panel Buprenorphine & MDMA Compact Drug Test Cup – 90 mL | AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY & THC

In Stock

$5.99$2.60/each

Buy More, Save More
Quantity
1

Description

10 DRUG PANELS • BUPRENORPHINE & MDMA • COMPACT 90 mL

10-Panel Buprenorphine & MDMA Compact Drug Test Cup

Broad preliminary urine drug screening in a compact, easy-to-store 90 mL format.

This self-contained urine drug test cup screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.

The compact 90 mL design provides sufficient specimen capacity while using less storage space than a standard-size cup. Collection, temperature verification and preliminary drug screening take place in one convenient device, with results available in approximately five minutes.

Product Highlights

Ten-Drug Screening Screens for AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC.
Dedicated Buprenorphine Panel Screens for buprenorphine at the manufacturer-listed 10 ng/mL cutoff.
Dedicated MDMA Panel Screens for MDMA or ecstasy at the listed 500 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI and OXY screening panels.
Compact 90 mL Capacity Provides sufficient specimen volume in a smaller, easier-to-handle format.
Space-Saving Design Easier to transport, organize and store in high-volume testing environments.
Results in 5 Minutes Provides clear preliminary results for efficient onsite screening.
One-Step Testing Collection and preliminary screening are completed using one integrated device.
Leak-Resistant Screw Lid Secure closure helps reduce spills, leakage and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
User-Friendly Format Clearly marked test and control regions simplify preliminary interpretation.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Ten Drug Panels in a Compact 90 mL Collection Cup A practical screening option for healthcare facilities, occupational health clinics, treatment programs, collection sites, correctional settings and authorized workplace testing.

Drug Panels and Cutoff Levels

Review the ten drug categories and manufacturer-listed preliminary screening cutoff levels.

TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF
AMP   AMP   AMP   AMP   AMP
AMP   AMP   AMP   AMP   AMP
 Amphetamines 1–2 Days • 1,000 ng/mL
BUP   BUP   BUP   BUP   BUP
BUP   BUP   BUP   BUP   BUP
 Buprenorphine 2–6 Days • 10 ng/mL
BZO   BZO   BZO   BZO   BZO
BZO   BZO   BZO   BZO   BZO
 Benzodiazepines 1–2 Days • 300 ng/mL
COC   COC   COC   COC   COC
COC   COC   COC   COC   COC
 Cocaine 2–4 Days • 300 ng/mL
MDMA   MDMA   MDMA   MDMA
MDMA   MDMA   MDMA   MDMA
 MDMA / Ecstasy 2–4 Days • 500 ng/mL
MET   MET   MET   MET   MET
MET   MET   MET   MET   MET
 Methamphetamine 2–4 Days • 1,000 ng/mL
MTD   MTD   MTD   MTD   MTD
MTD   MTD   MTD   MTD   MTD
 Methadone 1–3 Days • 300 ng/mL
OPI   OPI   OPI   OPI   OPI
OPI   OPI   OPI   OPI   OPI
 Morphine / Opiates 2–3 Days • 300 ng/mL
OXY   OXY   OXY   OXY   OXY
OXY   OXY   OXY   OXY   OXY
 Oxycodone 1–3 Days • 100 ng/mL
THC   THC   THC   THC   THC
THC   THC   THC   THC   THC
 Marijuana 5+ Days • 50 ng/mL
Please Note: Detection windows vary by dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors. Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions.
Dedicated Buprenorphine and Oxycodone Panels Buprenorphine and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Separate BUP and OXY strips provide targeted preliminary screening for each listed analyte.
Dedicated MDMA Screening The MDMA panel screens for ecstasy-related compounds identified in the manufacturer’s package insert at the listed 500 ng/mL cutoff.
Compact Without Sacrificing Function The 90 mL cup integrates specimen collection, temperature verification and ten-panel screening into one device while reducing storage space and material use.

How to Use the 10-Panel Buprenorphine & MDMA Compact Drug Test Cup

Understanding the 10-Panel Buprenorphine & MDMA Compact Drug Test Cup Results


Product Dimensions and Specifications

10-Panel Buprenorphine & MDMA Compact Drug Test Cup
Drug Panels AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC
Buprenorphine Cutoff BUP/10
MDMA Cutoff MDMA/500
Methadone Cutoff MTD/300
Opiate Cutoff OPI/300
Oxycodone Cutoff OXY/100
Result Time Approximately 5 minutes
Capacity 90 mL
Height 2.53 inches
Bottom Width 2.12 inches
Lid Width 2.75 inches
Approximate Weight 0.14 lb

CLIA-Waived Testing

According to the supplied manufacturer information, this 10-panel compact test cup is CLIA waived for the intended uses identified in its labeling. Eligible point-of-care sites may use waived tests under a CLIA Certificate of Waiver when the manufacturer’s instructions are followed exactly.

Simple Point-of-Care Format The self-contained design allows specimen collection and preliminary screening without complex laboratory equipment.
Follow Exact Labeling Regulatory status, intended use and permitted testing settings apply only to the exact cup configuration and assays identified on the packaging.

Depending on its exact labeling and applicable requirements, this compact cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites, probation and correctional programs and qualifying workplace-screening programs.

Regulatory Notice: Confirm the CLIA status and any FDA 510(k) clearance shown on the exact product packaging before advertising, purchasing or use. State and local testing requirements may also apply.

Frequently Asked Questions

1. Which substances does this 10-panel cup screen for? It screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.
2. Does the smaller 90 mL size affect the test panel? No. The compact cup still provides sufficient specimen capacity for the integrated ten-panel screening process when used according to the manufacturer’s instructions.
3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Do not interpret results after eight minutes or outside the package insert’s stated reading window.
5. What does the built-in temperature strip verify? It measures specimen temperature shortly after collection and helps identify samples that fall outside the expected collection-temperature range.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, legal or treatment decisions are made.
Ten Drug Panels. Buprenorphine and MDMA Screening. Compact 90 mL Design. Simplify preliminary urine drug screening with a compact, self-contained cup designed for secure collection, rapid results and convenient storage.
Order 10-Panel Compact Test Cups Today

Shipping & Delivery

  • All orders will be shipped the same day if placed before 3:00 PM EST.
  • Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.

Why order from us

  • CLIA-waived screening supplies for qualified lab and point-of-care workflows.
  • Same-day shipping on orders placed before 3:00 PM EST.
  • Volume and bulk pricing available — contact us for recurring supply.